Clinical Trials Directory
We are doing this study to better understand how HIV affects the body.
We are doing this study to compare two different treatments to see which is better for treating children with this type of brain cancer. The drugs in this study have all been used to treat children with brain cancer, but what is new is the way they are being given. In addition to comparing how well these treatments work, we will evaluate their effects on each child's quality of life, brain function, and hearing.
We are doing this study to collect blood samples that may be used for the following:
- To make sure equipment and assays are working properly
- Staff training
- Researching assay development (an assay is a laboratory test)
We are doing this study to find out if giving the drugs floxuridine and oxaliplatin directly into the hepatic artery of the liver is a safe and effective option for patients with localized pancreatic ductal adenocarcinoma. This form of drug delivery will be combined with surgery and standard chemotherapy in this study. Chemotherapy can happen either before or after the delivery of drugs directly into the hepatic artery. We also want to see how this regimen works to improve the rate of liver metastasis (cancer that has spread to the liver) after surgery.
We are doing this study to find out if an experimental drug called etavopivat (the study drug) is a safe and effective option for managing pain flares from sickle cell disease.
We are doing this study to learn if hyperbaric oxygen therapy is helpful to people with traumatic brain injury.
We are doing this study to evaluate the safety and performance of a medical technology called the Medtronic Hugo® RAS system (the study device) in hernia repair robotic assisted surgery (RAS) procedures.
If you agree to be in the study, you will have 1 study visit that will last about 4 hours. The visit will include asking questions about your medical history, vital signs, pulmonary function tests (PFTs) and an MRI (magnetic resonance image) of the chest with inhaled Xenon gas. Someone from the study team will contact you about 24 hours after your study visit.